News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
424,727 Results
Type
Article (31050)
Company Profile (113)
Press Release (393564)
Multimedia
Podcasts (53)
Webinars (10)
Section
Business (109712)
Career Advice (577)
Deals (19036)
Drug Delivery (90)
Drug Development (45020)
Employer Resources (85)
FDA (11226)
Job Trends (10535)
News (190586)
Policy (21873)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2291)
Academic (2)
Accelerated approval (2)
Adcomms (13)
Allergies (57)
Alliances (31040)
ALS (53)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (83)
Approvals (11279)
Artificial intelligence (209)
Autoimmune disease (15)
Automation (9)
Bankruptcy (152)
Best Places to Work (9339)
BIOSECURE Act (13)
Biosimilars (83)
Biotechnology (64)
Bladder cancer (47)
Brain cancer (17)
Breast cancer (176)
Cancer (1328)
Cardiovascular disease (133)
Career advice (530)
Career pathing (10)
CAR-T (65)
Cell therapy (218)
Cervical cancer (15)
Clinical research (35806)
Collaboration (561)
Compensation (67)
Complete response letters (10)
COVID-19 (2316)
CRISPR (23)
C-suite (148)
Cystic fibrosis (73)
Data (1389)
Decentralized trials (2)
Denatured (16)
Depression (30)
Diabetes (191)
Diagnostics (5007)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (25)
Drug discovery (78)
Drug pricing (101)
Drug shortages (10)
Duchenne muscular dystrophy (57)
Earnings (36565)
Editorial (27)
Employer branding (10)
Employer resources (75)
Events (75614)
Executive appointments (521)
FDA (12120)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (543)
Gene editing (54)
Generative AI (22)
Gene therapy (167)
GLP-1 (469)
Government (4274)
Grass and pollen (4)
Guidances (42)
Healthcare (15380)
Huntington's disease (11)
IgA nephropathy (14)
Immunology and inflammation (60)
Indications (18)
Infectious disease (2449)
Inflammatory bowel disease (99)
Inflation Reduction Act (10)
Influenza (48)
Intellectual property (49)
Interviews (67)
IPO (8086)
IRA (37)
Job creations (1629)
Job search strategy (477)
Kidney cancer (7)
Labor market (14)
Layoffs (206)
Leadership (5)
Legal (4214)
Liver cancer (48)
Lung cancer (199)
Lymphoma (84)
Machine learning (5)
Management (32)
Manufacturing (181)
MASH (44)
Medical device (9531)
Medtech (9534)
Mergers & acquisitions (11302)
Metabolic disorders (483)
Multiple sclerosis (58)
NASH (10)
Neurodegenerative disease (50)
Neuropsychiatric disorders (17)
Neuroscience (1335)
NextGen: Class of 2025 (5161)
Non-profit (4003)
Northern California (1544)
Now hiring (8)
Obesity (258)
Opinion (139)
Ovarian cancer (33)
Pain (48)
Pancreatic cancer (32)
Parkinson's disease (84)
Partnered (14)
Patents (125)
Patient recruitment (73)
Peanut (32)
People (34969)
Pharmaceutical (33)
Pharmacy benefit managers (17)
Phase I (11508)
Phase II (14574)
Phase III (12345)
Pipeline (753)
Policy (122)
Postmarket research (1736)
Preclinical (5101)
Press Release (55)
Prostate cancer (64)
Psychedelics (27)
Radiopharmaceuticals (160)
Rare diseases (266)
Real estate (3071)
Recruiting (32)
Regulatory (14911)
Reports (21)
Research institute (1999)
Resumes & cover letters (44)
Rett syndrome (3)
RNA editing (3)
RSV (39)
Schizophrenia (48)
Series A (88)
Series B (66)
Service/supplier (6)
Sickle cell disease (50)
Southern California (1256)
Special edition (9)
Spinal muscular atrophy (95)
Sponsored (19)
Startups (2268)
Stomach cancer (10)
Supply chain (49)
Tariffs (29)
The Weekly (35)
United States (14716)
Vaccines (613)
Venture capitalists (27)
Weight loss (153)
Women's health (32)
Worklife (6)
Date
Last 7 days (391)
Last 30 days (1519)
Last 365 days (21667)
2025 (6741)
2024 (23065)
2023 (25848)
2022 (35602)
2021 (39169)
2020 (39444)
2019 (34634)
2018 (25988)
2017 (19216)
2016 (20229)
2015 (22853)
2014 (17125)
2013 (13727)
2012 (14552)
2011 (15093)
2010 (13029)
Location
Africa (559)
Alabama (30)
Alaska (6)
Arizona (125)
Arkansas (12)
Asia (23621)
Australia (4370)
California (3430)
Canada (1361)
China (324)
Colorado (175)
Connecticut (200)
Delaware (85)
Europe (52372)
Florida (581)
Georgia (163)
Hawaii (1)
Idaho (38)
Illinois (370)
India (22)
Indiana (275)
Iowa (7)
Japan (121)
Kansas (79)
Kentucky (16)
Louisiana (11)
Maine (66)
Maryland (642)
Massachusetts (2752)
Michigan (144)
Minnesota (233)
Mississippi (2)
Missouri (83)
Montana (16)
Nebraska (19)
Nevada (46)
New Hampshire (52)
New Jersey (1274)
New Mexico (12)
New York (1173)
North Carolina (667)
North Dakota (3)
Northern California (1544)
Ohio (135)
Oklahoma (9)
Oregon (24)
Pennsylvania (908)
Puerto Rico (6)
Rhode Island (24)
South America (713)
South Carolina (15)
South Dakota (1)
Southern California (1256)
Tennessee (88)
Texas (498)
Utah (152)
Virginia (85)
Washington D.C. (46)
Washington State (403)
West Virginia (3)
Wisconsin (47)
424,727 Results for "merck animal health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Sales of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks. Sales of the vaccine were $539 million for the quarter, a 5% decline from the same period in 2024.
April 24, 2025
·
2 min read
·
Annalee Armstrong
Policy
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.
June 25, 2024
·
6 min read
Cancer
Merck’s Injectable Keytruda Matches IV Formula in Pivotal Trial
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Merck Animal Health to Acquire Elanco’s Aqua Business
Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.
February 5, 2024
·
7 min read
Collaboration
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M
Merck has not disclosed which of its peptide therapies it plans to develop oral formulations for.
April 15, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Merck’s Winrevair Cuts Morbidity, Mortality Risk by Over 75% in Phase III PAH Study
Merck continues to build the case for the pulmonary arterial hypertension drug that won FDA approval in 2024.
April 1, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Merck Animal Health’s Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration with the American Veterinary Medical Association.
January 15, 2024
·
12 min read
Press Releases
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
3 min read
Earnings
Merck’s Gardasil Woes Grow as China Trade War Heats Up
Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.
February 4, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
Merck, Bristol Myers Squibb, Sanofi and Roche had little clarity on the potential impact of President Donald Trump’s pharmaceutical tariffs but many companies are already preparing for what’s to come.
April 24, 2025
·
3 min read
·
Annalee Armstrong
1 of 42,473
Next
